loadpatents
name:-0.023792028427124
name:-0.016282796859741
name:-0.0071029663085938
SMITH; Jill P. Patent Filings

SMITH; Jill P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SMITH; Jill P..The latest application filed is for "treating cancer with a cck receptor inhibitor and an immune checkpoint inhibitor".

Company Profile
5.17.22
  • SMITH; Jill P. - Camp Hill PA
  • Smith; Jill P. - Washington DC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treating Cancer With A Cck Receptor Inhibitor And An Immune Checkpoint Inhibitor
App 20220257609 - SMITH; Jill P. ;   et al.
2022-08-18
Nanoparticle To Target Cancer
App 20220211738 - Smith; Jill P. ;   et al.
2022-07-07
Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor
Grant 11,278,551 - Smith , et al. March 22, 2
2022-03-22
Nanoparticle to target cancer
Grant 11,246,881 - Smith , et al. February 15, 2
2022-02-15
Treating Non-alcoholic Steatohepatitis With Cck Inhibitors
App 20220000819 - SMITH; Jill P.
2022-01-06
Encapsulation And High Encapsulation Efficiency Of Phosphorylated Active Agents In Nanoparticles
App 20210338705 - Adair; James H. ;   et al.
2021-11-04
Compositions And Methods For Preventing Tumors And Cancer
App 20210275649 - Sutton; Lynda ;   et al.
2021-09-09
Combinatorial Therapies For The Treatment Of Neoplasias Using The Opioid Growth Factor Receptor
App 20210046147 - Zagon; Ian S. ;   et al.
2021-02-18
Treating Cancer With A Cck Receptor Inhibitor And An Immune Checkpoint Inhibitor
App 20200383996 - Smith; Jill P. ;   et al.
2020-12-10
Compositions And Methods For Inducing Humoral And Cellular Immunities Against Tumors And Cancer
App 20200206332 - Sutton; Lynda ;   et al.
2020-07-02
Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
Grant 10,668,126 - Zagon , et al.
2020-06-02
Encapsulation And High Loading Efficiency Of Phosphorylated Drug And Imaging Agents In Nanoparticles
App 20190255087 - Adair; James H. ;   et al.
2019-08-22
Nanoparticle To Target Cancer
App 20190076457 - Smith; Jill P. ;   et al.
2019-03-14
Bioconjugation of Calcium Phosphosilicate Nanoparticles For Selective Targeting of Cells in Vivo
App 20170274100 - Adair; James H. ;   et al.
2017-09-28
Encapsulation And High Loading Efficiency Of Phosphorylated Drug And Imaging Agents In Nanoparticles
App 20170209478 - Adair; James H. ;   et al.
2017-07-27
Method for treating tumors that possess the CCK-C receptor with the 3B9.1 monoclonal antibody
Grant 9,562,095 - Smith February 7, 2
2017-02-07
Combinatorial Therapies For The Treatment Of Neoplasias Using The Opioid Growth Factor Receptor
App 20160256517 - Zagon; Ian S. ;   et al.
2016-09-08
Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
Grant 9,375,458 - Zagon , et al. June 28, 2
2016-06-28
Method For Treating Tumors That Possess The CCK-C Receptor With The 3B9.1 Monoclonal Antibody
App 20160168246 - Smith; Jill P.
2016-06-16
Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivo
Grant 9,149,544 - Morgan , et al. October 6, 2
2015-10-06
Composition and method for the treatment of gastrin mediated cancers
Grant 8,889,640 - Smith , et al. November 18, 2
2014-11-18
Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancer
Grant 8,821,872 - Smith , et al. September 2, 2
2014-09-02
Combinatorial Therapies For The Treatment Of Neoplasias Using The Opioid Growth Factor Receptor
App 20130084242 - Zagon; Ian S. ;   et al.
2013-04-04
Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
Grant 8,003,630 - Zagon , et al. August 23, 2
2011-08-23
Bioconjugation of Calcium Phosphosilicate Nanoparticles For Selective Targeting of Cells In Vivo
App 20110129413 - Morgan; Thomas T. ;   et al.
2011-06-02
Combinatorial Therapies For The Treatment Of Neoplasias Using The Opioid Growth Factor Receptor
App 20110123437 - ZAGON; IAN S. ;   et al.
2011-05-26
Identification and Characterization of a Specific CCK-C Receptor Antibody for Human Pancreatic Cancer and Its Use for Early Detection and Staging of Pancreatic Cancer
App 20110052668 - Smith; Jill P. ;   et al.
2011-03-03
Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonists
Grant 7,879,870 - Smith , et al. February 1, 2
2011-02-01
Treatment Of Inflammatory And Ulcerative Diseases Of The Bowel With Opioid Antagonists
App 20080015211 - Smith; Jill P. ;   et al.
2008-01-17
Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
App 20070053838 - Zagon; Ian S. ;   et al.
2007-03-08
Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
App 20050191241 - Zagon, Ian S. ;   et al.
2005-09-01
Control of cancer growth through the interaction of [MET5]-enkephalin and the zeta receptor
Grant 6,737,397 - Zagon , et al. May 18, 2
2004-05-18
Use of amantadine for treatment of Hepatitis C
Grant 5,849,800 - Smith December 15, 1
1998-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed